On Tuesday, Wave Life Sciences Ltd (NASDAQ: WVE) was 7.43% up from the session before settling in for the closing price of $13.45. A 52-week range for WVE has been $3.50 – $16.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 610.91%. When this article was written, the company’s average yearly earnings per share was at -113.04%. With a float of $117.59 million, this company’s outstanding shares have now reached $148.39 million.
Considering the fact that the conglomerate employs 268 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 16.52%, operating margin of -283.63%, and the pretax margin is -265.84%.
Wave Life Sciences Ltd (WVE) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Wave Life Sciences Ltd stocks. The insider ownership of Wave Life Sciences Ltd is 22.90%, while institutional ownership is 73.94%. The most recent insider transaction that took place on Nov 25 ’24, was worth 750,000. In this transaction President and CEO of this company sold 50,000 shares at a rate of $15.00, taking the stock ownership to the 217,351 shares. Before that another transaction happened on Nov 25 ’24, when Company’s Officer proposed sale 50,000 for $15.00, making the entire transaction worth $750,000.
Wave Life Sciences Ltd (WVE) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -113.04% per share during the next fiscal year.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
You can see what Wave Life Sciences Ltd (WVE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 41.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Compared to the last year’s volume of 1.11 million, its volume of 1.14 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 19.75%. Additionally, its Average True Range was 0.96.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 80.46%, which indicates a significant increase from 40.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.47% in the past 14 days, which was lower than the 130.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.89, while its 200-day Moving Average is $7.95. Nevertheless, the first resistance level for the watch stands at $14.96 in the near term. At $15.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $16.40. If the price goes on to break the first support level at $13.52, it is likely to go to the next support level at $12.60. Now, if the price goes above the second support level, the third support stands at $12.08.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are 152,520K outstanding shares of the company, which has a market capitalization of 2.20 billion. As of now, sales total 113,310 K while income totals -57,510 K. Its latest quarter income was 19,690 K while its last quarter net income were -32,920 K.
